SMAD6 and gastric cancer: The survival time of GC patients with high expression of CALML4 or SMAD6 was significantly longer than that of patients with low mRNA expression of CALML4 (P = 0.02146, Figure 3(a)) or SMAD6 (P = 0.03213, Figure 3(d)).